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Abstract--Human neutmphils which are pretreated with subtoxic concentrations of 
a variety of lysophosphatides (lysophosphatidytcholine, lysophosphatidylcholine 
oleoyl, lysophosphatidylcholine myfioyl, lysophosphatidyleholine stearoyl, lyso- 
phosphatidylcholine gamraa-O-hexadecyl, lysophosphatidylinos~tol, and lysophos- 
phatidylglycerol) act synergistically with neutmphil agonists phorbol myfistate 
acetate, immune complexes, poly-L-histidine, phytohemagglutinin, and N-formyl- 
methionyl-leucyl-phenyalanine to cause enhanced generation of superoxide (O~). 
None of the lyso compounds by themselves caused generation of Of. The lyso com- 
pounds strongly bound to the neutmphils and could not be washed away. All of the 
Iyso compounds that collaborated with agonists m stimulate O~ generation were 
hemolytic for human red blood cells. On the other hand, lyso compounds that were 
nonhemolytic for red blood cells (lysophosphatidylcholine caproate, lysophosphati- 
dylcholine decanoyl, lysophosphatidylethanolamine, [ysophosphatldylserine) failed 
to collaborate with agonists to generate synergistic amounts of 02 .  However, in the 
presence of cytochalasin B, both lysophosphatidylethanolamine and lysophosphati- 
dylserine also markedly enhanced Oz generation induced by immune complexes. 
O~ generation was also very markedly enhanced when substimulatory amounts of 
arachidonic acid or eicosapentanoic acid were added to PMNs in the presence of a 
variety of agonists. On the other hand, neither phospholipase C, streptolysin S (highly 
hemolytic), phospholipase A2, phosphatidylcholine, nor phosphatidytcholine dipal- 
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mitoyl (all nonhemolytic) had the capacity to synergize with any of the agonists 
tested to generate enhanced amounts of 07 .  The data suggest that in addition to 
long-chain fatty acids, only those lyso compounds that possess fatty acids with more 
than I0 carbons and that are also highly hemolytic can cause enhanced generation 
of O z in stimulated PMNs. 
INTRODUCTION 
Recent studies from our laboratory (1-5) have described the role played by 
polycationic agents poly-L-arginine (PARG) and poly-L-histidine (PHSTD) as 
potent activators of the respiratory burst in human neutrophils (PMNs). It was 
also shown that a "cocktail" comprised of PARG, phytohemagglutinin, and 
cytochalasin B (CYB) caused generation of large amounts of superoxide (O~-) 
in human PMNs. Since a variety of cytolytic agents (lysophosphatidyleholine, 
digitonin, saponin) were able to replace PARG in the cocktail (5) and since 
PARG was also highly cytotoxic, we postulated that membrane-active agents 
including lysophosphatides might cause PMNs challenged with agonists known 
to activate the NADPH oxidase of PMNs (6, 7) to generate higher amounts of 
oxygen radicals. The present communication extends our earlier observations 
(5) and investigates in a systematic way the role played by lysophosphatides 
and certain fatty acids as potentiators of 0 2  generation in stimulated PMNs. 
The possible role played by lysophosphatides as amplifiers of the inflammatory 
response is discussed. 
MATERIALS AND METHODS 
Blood Neutrophils (PMNs). Human blood ]n heparin (10 units/rot) was drawn from healthy 
donors. PMNs were isolated on a Ficoll-Hypaque gradient as described in detail elsewhere (4). 
Such preparations contained greater than 95% viable PMNs. Erythroeytes were removed by treat 
ment with hypotonic saline followed by washing with normal saline buffered with 0.01 M phos- 
phate, pH 7.3. The washed leukocytes were resuspended in Hanks' balanced salt solution (HBSS) 
buffered with 3 mM HEPES, pH 7.33, or in HBSS plus HEPES to which 10 mM sodium azide 
was added and kept on ice. Viability of the PMNs was evaluated by the trypan blue exclusion 
technique. 
Measurement of Superoxide (07.). Superoxide was determined in stimulated PMNs by the 
reduction of eytochrome c (80 ktM, type III, Sigma Chemical Company, St. Louis, Missouri) 
according to the method of Babior (7). The reaction mixtures contained 1-5 X 106/ml PMNs, and 
appropriate ligand (see below), cytocbrome e, with or without 20 ~g/mI superoxide dismutase 
(SOD) in a final volume of 1.0 ml. In some experiments, we examined the effect of  CYB on 0 2  
generation induced by the various ligands. The CYB was dissolved in dimethyl sulfoxide (DMSO) 
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at 500/zg/ml, and 2.5 t~gim[ were employed. All reaction mixtures were incubated in a water bath 
at 37~ for various time intervals and then centrifuged at 1000g for 5 rain. The optical density of 
supematant fluids was read 550 urn. The amount of O~- was calculated from the extinction values 
using the formula E~ o = 2.1 x 10 -4 M and was expressed as nanomoles per given number of 
ceIts per 10 min. 
Measurement of Hydrogen Peroxide (H202). Hydrogen peroxide was determined in stim- 
ulated PMNs by the method described by Thurman et al. (9). Briefly, to stimulated PMNs in HBSS 
plus NaN3 (i0 mM) (final volume of 1.0 ml), we added 200 ~1 of TCA (30%). The tubes were 
centrifuged at t000g for 5 rain, The clear supernates were transferred to clean tubes, and 200 t*t 
of Fe(NH4)2(SO4) "6H20 (19 mg/5 ml of water) plus 100 tA of KCNS (25 % ) were added. The tubes 
were agitated and incubated for 5 rain at room temperature, and the brown color that developed 
was read in a spectrophotometer at 480 nm. A standard curve for hydrogen peroxide was prepared 
on the day of the experiment. The results were expressed as nanomoles per number of leukocytes 
per 10 rain. Catalase (100 ttg/mL from bovine liver, 17,600 Sigma units/mg protein) was included 
in control tubes. 
Stimulation of Oxygen Radical Generation. PMNs ( l -3  • t06/ml) in HBSS containing 
sodium azide (10 raM) were treated for 15 rain at 37~ with (A) PHSTD (molecular weight 15,000); 
(B) an immune complex (8) prepared by mixing 50 vl of a rabbit anti-bovine serum albumin (BSA) 
immune globulin containing 2 mg of protein nitrogen/ml, with 25 p,g of BSA (6 mg/ml) (the result- 
ing preeipate was washed in saline and resuspended to the same volume); and (C) Iipoteichoic 
immune complex [PMNs were pretreated for 10 rain at 37~ with 25 #g/ml of lipoteichoic acid 
(LTA) derived from Streptococcus pyogenes (10); the PMNs were washed in HBSS and treated 
with a rabbit anti-LTA globulin containing 250 #g protein/ml in the presence of a cytochrome el; 
(D) the chemotactic peptide formyl-methionyl-leucyl-phenylalanine (FMLP) (10-~-10 -8 M); (E) 
phytobemagglutinin (PHA 50 #g/ml) derived from Phaseoulus vulgaris; (F) phorbol myristate ace- 
tate (PMA) (1-5 #g/ml); and (G) streptococci opsonized with rabbit anti-streptococcal serum and 
with complement (10). 
Modulation of 02 Generation. The following agents were tested for their capacity to mod- 
ulate the generation of O~- and H202: L~et-lysophosphatidylcholine from egg yolk, from bovine 
brain, and from bovine liver; L-e~-lysophosphafidylcholine caproyl; L-c~-lysophosphatidylcholine 
oleyl; L-~x-lysophosphatidytcholine decanoyl; L-e~-lysophosphatidylcholine myristoyl; L-c~-lysn L 
phosphatidylcholine stearoyt; DL-o~-lysophosphatidyleholine gamma-O-hexadecyi; L-~-lysophos- 
phatidic acid oleyl sodium; L-otqysophosphatidyl L-~-serine; lysophospbatidyletbanolamine; L-e~- 
lysophosphatidylinositol; L-o,-lysophosphatidyl DL-glycerole; phosphatidylcholine; DL-oc-phospha- 
tidylcholine dipalmytoyl; palmitie acid; arachidonic acid; 5,8,11,15,17-eicosapentonic acid; phos- 
pholipase Az (from bee venom); phospholipase Az (from Naja Naja); phospholipase C (from Clost. 
welchii); and streptolysin S. All these agents were obtained from Sigma Chemical Company. The 
agents were either dissolved in saline or in ethanol followed by the addition of boiling water. All 
materials were kept at -20~  Human PMNs (1-3 x 106/ml) in HBSS containing cytochrome c 
were pretreated for 1 rain at room temperature with the various agents folIowed by the addition of 
a series of agonists (see above). In some experiments CYB (2.5 tzg/ml) was included in the reaction 
mixtures, We also tested the superoxide-generating capacities of the various materials in the absence 
of added agonist. 
Determination of Hemolytic Activity. One-milliliter aliquots of 1% suspension of human 
red blood cells in HBSS were treated for 15 min at 37~ with the various lipids or enzymes. The 
tubes were centrifuged at 1000g for 5 rain, and the degree of hemolysis was assayed by measuring 
the absorption at 540 nm of the hemoglobin released. One hemolytic unit was determined to be as 
the smallest amount of agent that released 50 % of the hemoglobin after 15 rain of incubation. 
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RESULTS 
Synergistic Effect of Lyso Compounds and Various Agonists in Superoxide 
Generation. Since lyso compounds are generally known to be hemolytic for 
red blood cells and cytotoxic for nucleated cells, we first determined the IDso 
for the various agents employing human red blood cells as targets. Table 1 
shows that, except for lysophosphatidylcholine caproate, lysophosphatidylcho- 
line decanoyl, lysophosphatidylethanolamine, and lysophosphatidylserine, all 
of the other lysocompounds tested were hemolytic for red blood cells at con- 
centrations ranging from 5 to 10 t*M. The various iyso compounds were tested 
for their capacity to enhance O2 generation in PMNs stimulated by various 
agonists using concentrations that induced less than 50 % hemolysis of red blood 
Table !. Superoxide-Enhancing and Hemolytic Activities of Various Agents 
Compound tested ~ Hemolysis 
Molarity inducing 
O{ enhancement 
Lysophosphatidylcholine (egg yolk) 
Ly sophosphatidyLcholine (brain) 
Lysophosphatidylcholine (liver) 
Ly sophosphatidyicholine caproate 
Lysophosphatidylcholine decanoyl 
Ly sophosphatidy Icholine oleyl 
Ly sophosphatidylcholine myristoyl 
Lysophosphatidylstearoyl 
Ly sophosphatidylcholine-O-hexadecyl 








Phospholipase A 2 (bee venom) 
Phospholipase A2 (Naja naja) 
Phospholipase C 
Streptolysin S 
8/zM 1-3 #M 
8 ttM 1-4 #tM 
8~M 1 4ttM 
None (10 mM) None (10 mM) 
None (10 raM) None (10 raM) 
10 #M 3-5 t~M 
20 #M 5-7 t~M 
6 t~M 2.5-4,0 ~zM 
15/zM 2-5 ttM 
None (10 raM) None (10 rnM/' 
None (18 raM) None (100 raM/~ 
15 #M 5-12.5 /~M 
20 #M l-2 ~M 
None (200 t~M) 30-50 tzM 
None (200 ~M) 30-50 #M 
500-700/~M 10-20 ~M 
None (25 units/mI) None 
None (25 units/ml) None 
0.0125 units/ml None 
100 H units/ml None 
~PMNs were treated for I rain at room temperature with the various compounds. The concentra 
tions of the various agents employed to enhance O~- generation were below their hemolytic activity 
for a 1% suspension of human veal blood cells. O~ generation was initiated either by BSA immune 
complex, poly-L-histidine, or PMA. 
r marked enhancement of O~ generation took place only in the presence of CYB (see Figure 6). 
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cells. Nonlytic compounds were tested at a wider range of concentrations. Fig- 
ures 1-5 show the synergistic effects of lysophosphatides with a variety of ago- 
nists on 02  generation. All the lyso compounds that enhanced 02 generation 
also increased the production of hydrogen peroxide (not shown). None of the 
lyso compounds by themselves caused 02  generation when employed in the 
absence of neutrophil agonists. Table 1 also shows that all the other lyso com- 
pounds that hemolysed red blood cells also had the capacity to enhance 02  
generation in stimulated PMNs. Of the lysophosphatides that failed to enhance 
02  generation, two possessed fatty acids with less than 11 carbons (lysophos- 
phatidylcholine caproate and lysophosphatidylcholine decanoyl). The other two 
nonactive compounds had a polar base (lysophosphatidylserine and lysophos- 
phatidylethanolamine), Table 1 also shows that not all the agents that were 
hemolytically active enhanced 02- generation in stimulated PMNs. Specifically, 
neither phospholipase C nor streptolysin S affected the 02  response in neutro- 
phils. 
Since CYB is known to enhance 02 generation induced by a variety of 
both soluble and particulate agents (2, 11, 12), it was of interest to determine 
whether lyso compounds that were nonhemolytic and did not enhance 0~- gen- 
eration might do so in the presence of CYB. Figure 6 shows that in the presence 
0 
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Fig. 1, Effect of [ysophosphatidylcholine (LL) on 02 generation induced by BSA immune corn 
plex. PMNs (2 • i06/ml) were treated with increasing amounts of BSA complex in the absence 
(  9  O) and in the presence of LL (2.5 t~g/m[ ( e -  e) .  Note the marked enb, ancement of 
Oz generation in the presence of LL and that LL by itself did not generate Oz above the control 
!evels. 
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Fig. 2. Effect of lysophosphatidylcholine (LL) on O~- generation induced by lipoteichoic acid 
immune complex. PMNs (3 x 106/ml) were pretreated for 15 rain with lipoteiehoic acid (LTA). 
The cells were washed and resuspended in ttBSS and further treated for 1 rain at room temperature 
with increasing amounts of LL followed by the addition of anti-LTA globulin (250/zg proteintml), 
Note that maximal stimulation of 02  generation 9 - -  9 took place with 2.5 t~g/ml of LL, which 
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Fig. 3, Effect of lysopho~phatidylchotine (LL) on 02  generation by poty-L-histidine (PHSTD). 
Untreated PMNs (2 • 106/ml) (9 ~ C)) and PMNs pretreated for l vain at room temperature 
w~th LL (2.5 ~g/ml) ( e  - -  O) were challenged with increasing amounts of PHSTD. Note the 
marked enhancement of 02  generated by the combined effect of LL and PHSTD. 
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Fig. 4. Effect of lysophosphatides on 02  generation induced by various agonists. PMNs (3 x 106/ 
ml) were treated with (A) FMLP (10 6 M), (B) FMLP + LL (2.5 ~g/mt), (C) phytohemagglutinin 
(PHA) (50 ~zg/ml), (D) PHA + LL, (E) PMA (3 ng/ml), (F) PMA + LL, (G) PMA + lysophos- 
phatidylglycerole (t .5 ~g/mI), (H) PMA + lysophosphatidylinositol (2.5/~g/rnl), (I) LL alone, (J) 
lysophosphatidylglyeerol alone, and (K) lysophosphatidylinositol alone. Note the enhanced gen- 
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Fig. 5. Effect of ]ysophosphatidylinositol (LPI) on Oz generation induced by two agonists. PMNs 
(2 • 106/ml) were pretreated for 1 min at room temperature with increasing amounts of LPI, The 
cells were then challenged either with poly-u-Histidine (PHSTD) (75 ~g/mt) (9 i 9 or with 
BSA immune complex (7.5 p.1) (O e ) .  Note the distinct synergistic effects of the lysophos- 
phatides with the two agonists on O_~ generation. LPI alone ( A t -  At) had no 02- generating 
ability. 
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o f  CYB even lysophosphat idylethanolamine and lysophosphatidylserine (not 
shown) were highly stimulatory to O2 generation when immune complexes or 
PHSTD were employed as agonists. 
Since the stimulatory effects of  the various lyso compounds might be related 
to the presence of  free fatty acid contaminating the preparations and since fatty 
acids have been shown to tr igger O2 generation by PMNs (13, 14), we tested 
the capacity of certain fatty acids to enhanceO~- generation in stimulated PMNs. 
Figure 7 shows that both araeidonie acid and eicosapentanoic acid at 10 /xM 
(nonhemolytic at concentrations up to 200 /xM) (Table 1) also markedly 
enhanced O2~ generation induced by PMA.  Similar  results (not shown) were 
also obtained when PHSTD or BSA immune complex were the agonists. Under 
similar conditions at concentrations up to 10 ~M, palmitic acid was only slightly 
stimutatory when employed in conjunction with either PMA,  PHSTD, or with 
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Fig. 6. Effect of CYB on O~ generation induced by lysophosphatidylethanolamine (LPEA) in the 
presence of BSA immune complex. PMNs (2 x 106/ml) were pretreated for 1 min at room tem- 
perature with increasing amounts of LPEA_ The cells were then further treated with BSA complex 
(7.5/zl) in the absence (e  - -  e)  and presence of CYB (2.5 /~g/ml) (O - -  9 Note that while 
in the absence of CYB, LPEA failed to generate appreciable amounts of 02, a distinct synergistic 
generation of O~- took place when PMNs were simultaneously treated with LPEA, BSA complex, 
and CYB. Neither LPEA (Ik) nor LPEA + CYB (A) in the absence of added agonist had the 
capacity to generate Oz. 














0 5 10 15 20 25 
LIPID (pg/ml)  
Fig. 7. Effect of free fatty acids on O,- generation induced by PMA. PMNs (2 x 106tml) were 
treated with increasing amounts of araehidonic acid (AA) (  9  - -   9  eicosapentanoic acid (EICO) 
(71 - -  [Z) with AA + PMA (33 ng/ml) (9 - -  9 and with EICO + PMA (O - -  O). Note the 
distinct synergistic generation of 02 when fatty acids act in collaboration with PMA. The concen- 
trations of the fatty acids that enhanced 02~ generation in the presence of an agonist were far beiow 
those that induced 02 generation in its absence. 
immune complexes (not shown). It should be noted that based on the dose-  
responses as compared to the amounts of  lysophosphatidylcholine (Figure 1) 
required for enhancement o f  0 2  responses in stimulated PMNs,  it seems 
unlikely that the effect of  the tysophosphatidyl  compounds can be ascribed to 
presence of  contaminating free fatty acids. 
D I S C U S S I O N  
The data presented show that the generation o f  0 2  by human PMNs is 
greatly enhanced in the cells that are pretreated with lysophosphatides and then 
challenged with a variety of  agonists (Table 1, Figures 1-5). 
The direct correlation between the hemolytic activity of  the various lyso 
compounds and their  capacity to synergize with agonists to generate enhanced 
amounts of  O~ is striking (Table 1). Nonhemolyt ic  compounds (lysophospha- 
t idylcholine caproate,  Iysophosphat idylcholine decanoyl) ,  that failed to hemo- 
lyse red blood cells also failed to act synergist ically with neutrophil agonists. 
Since these compounds possess fatty acids with less than 11 carbons, it appears 
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that the length of the fatty acid chain might play an important role as a mem- 
brane permeabilizing agent. Furthermore, since both lysophosphatidylserine and 
lysophosphatidylethanolamine (which contain primarily stearic and palmitic acid) 
also failed either to hemolyse or to synergize with the agonists, we suggest that 
the presence of polar groups in these substances interfered with the permeabit- 
ization of the membrane or with the O~--generating system. Since the concen- 
trations of the various lyso compounds that acted synergistically with the 
agonists were not cytotoxic, it appears that the various agents first interacted 
with some phospholipid targets in the PMNs membrane. This interaction 
"primed" the oxidase, which was then fully activated by a "second hit" (5, 
6). Since none of the lysophosphatides employed in this study had the capacity 
to induce Oy generation in the absence of added agonist (see also 13), these 
compounds differ from digitonin (15) and from free fatty acids (14), which are 
efficient O~--generating agents. Quantitatively, however, much larger amounts 
of the free fatty acids are needed to generate comparable amounts of O{ (Figure 
7). It seems, therefore, that the capacity of the various lyso compounds to syner- 
gize with the agonists is not due to contamination with free fatty acids. 
Since two hemolytic agents (phospholipase C and streptolysin S) failed to 
synergize with the various agonists in O~- generation, it appears that not every 
membrane-active agent has the capacity to prime the oxidase in the membrane. 
The mechanism by which the various lyric agents augment O~- generation in 
the presence of other agonists is not fully known. The inability of phospholipase 
A 2 and phospholopase C, when added externally, to stimulate 02  generation is 
intriguing. Since activation of NADPH oxidase is known to involve the acti- 
vation of the inositol phosphatide cascade (16-20) and the release of arachi- 
donic acid from membrane phospholipids with the concomitant accumulation 
of lyso compounds, it appears that when added externally these phospholipases 
fail to gain access to their substrates, which are the products involved in the 
ultimate activation of the oxidase. This can be achieved, however, by adding 
the degradation product of phospholipase Az, namely lysophosphatide. Further 
studies employing thin-layer chromatography might reveal whether or not the 
interaction of PLA2 with the cells resulted in the accumulation of lyso com- 
pounds in the membrane. 
More recently (21) it was also shown that lysophosphatidylcholine 
enhanced the generation of 02  induced by various soluble agonists. On the 
other hand, no such stimulation occurred when opsonized zymosan was the 
agonist. Our results vary from those described (2t) in several aspects and add 
new observations. (1) Employing similar concentrations of the various lyso 
compounds, we found a direct correlation between the length of the fatty acids 
present in the various compounds and their hemolytic and O2-generating capac- 
ities (Table t). (2) Although lysophosphatidylserine and lysophosphatidyl- 
ethanolamine failed to enhance 02  generation when tested with the various 
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agonists (21), they did so in the presence of CYB (Figure 6). (3) The degree 
of stimulation obtained in our studies is much larger than that described (21) 
(Figures 1-5). (4) Not only lyso compounds, but also fatty acids such as arach- 
idonic acid and eicosapentanoic acid, proved very effective primers of the oxi- 
dase when employed in collaboration with a variety of agonists (Figure 7). (5) 
The lyso compounds also markedly stimulated O2 generation by particulate 
agents such as opsonized streptococci (not shown) and by two immune com- 
plexes (Figures 1-3). Since it was found that nonmetabolizable analogs of plate- 
let-activating factor were also active as stimulators of 0 2  generation in the 
presence of PMA (21), it is unlikely that the enhancement of 0 2  generation 
was due to the acetylation of the lyso compounds to generate platelet activating 
factor. 
The significance of the synergistic effect of lysophosphatides with other 
agonists in the generation of large amounts of 0 2  might be important in sites 
of inflammation. Large amounts of lipid material are known to accumuIate in 
inflamed sites. PLA 2 released from activated PMNs or macrophages might gen- 
erate lyso compounds that further collaborate with other agonists, e.g., immune 
complexes, chemotactic peptide, etc., to generate large amounts of toxic oxy- 
gen species. 
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